ホーム › PubMed Lab 🤖 自分の AI で使う ⭐ 保存した論文

🔬 PubMed Lab

日本語で入力するだけで、PubMed の英語論文を検索できるリサーチアシスタントです。
卒論・研究テーマ探し、興味のある論文を効率よく見つけられます。

「慢性疲労症候群(CFS/ME)の最新治療エビデンス:運動療法・ペーシング・カンナビノイドまで総まとめ」の検索結果

8,101 件中 10 件を表示 (4378 ms) · ⭐ 保存した論文

AI が生成した英語クエリを見る
("Fatigue Syndrome, Chronic"[MeSH] OR "chronic fatigue syndrome" OR CFS OR "myalgic encephalomyelitis" OR ME/CFS) AND (therapy[MeSH Subheading] OR treatment OR "exercise therapy"[MeSH] OR "graded exercise" OR pacing OR "activity management" OR cannabinoids[MeSH] OR cannabis)

💡 CFS/MEの標準MeSH用語を使用し、運動療法・ペーシング・カンナビノイドの治療法を包括的にカバー

🎓 卒論・修論テーマを AI が提案

この 5 本の論文を俯瞰して、あなたが実際に卒論・修論で研究できるテーマを 3 つ提案します。

残り 3 / 3 回 (今日)

📖 このサイトの解説記事から (日本語で読める)

PubMed Trivia が過去に取り上げた論文を日本語で解説している記事です。

🔍 PubMed の検索結果

  • Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

    Stephanie L Grach, Jaime Seltzer, Tony Y Chon 他 · Mayo Clinic proceedings · 2023

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic neurologic disease often preceded by infection. There has been increased interest in ME/CFS recently because of its significant overlap with the post-COVID syndrome (long COVID or post-acute sequelae of COVID), with several studies estimating that half of patients with post-COVID syndrome fulfill ME/CFS criteria. Our concise …

    📄 PubMed で読む (PMID: 37793728)
  • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.

    Hayley E Arron, Benjamin D Marsh, Douglas B Kell 他 · Frontiers in immunology · 2024

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a chronic, debilitating disease characterised by a wide range of symptoms that severely impact all aspects of life. Despite its significant prevalence, ME/CFS remains one of the most understudied and misunderstood conditions in modern medicine. ME/CFS lacks standardised diagnostic criteria owing to variations in both inclusion and excl…

    📄 PubMed で読む (PMID: 38887284)
  • Patient-reported treatment outcomes in ME/CFS and long COVID.

    Martha Eckey, Peng Li, Braxton Morrison 他 · Proceedings of the National Academy of Sciences of the United States of America · 2025

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are persistent multisystem illnesses affecting many patients. With no known effective FDA-approved treatments for either condition, patient-reported outcomes of treatments may prove helpful in identifying management strategies that can improve patient care and generate new avenues for research. Here, we present the results …

    📄 PubMed で読む (PMID: 40627388)
  • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!

    Maria Eugenia Ariza · Biomolecules · 2021

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) or Systemic Exertion Intolerance Disease (SEID) is a chronic multisystem illness of unconfirmed etiology. There are currently no biomarkers and/or signatures available to assist in the diagnosis of the syndrome and while numerous mechanisms have been hypothesized to explain the pathology of ME/CFS, the triggers and/or drivers remain unkno…

    📄 PubMed で読む (PMID: 33572802)
  • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management.

    Lucinda Bateman, Alison C Bested, Hector F Bonilla 他 · Mayo Clinic proceedings · 2021

    Despite myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affecting millions of people worldwide, many clinicians lack the knowledge to appropriately diagnose or manage ME/CFS. Unfortunately, clinical guidance has been scarce, obsolete, or potentially harmful. Consequently, up to 91% of patients in the United States remain undiagnosed, and those diagnosed often receive inappropriate trea…

    📄 PubMed で読む (PMID: 34454716)
  • [Fatigue].

    Peter Lucassen, Sonja van Ockenburg, Rijk Gans 他 · Nederlands tijdschrift voor geneeskunde · 2022

    Many patients with fatigue do not visit a physician. In patients who do consult the general practitioner, the cause of their fatigue is explained in about a quarter: 8 percent has a somatic cause while psychosocial causes explain 16 percent. In about three quarters the cause of fatigue remains unexplained. Because of the low prevalence of somatic causes the general practitioner will be reluctant t…

    📄 PubMed で読む (PMID: 35736359)
  • Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): diagnosis and management.

    Jin Fan, Jiao Jiao, Hai-Qing Chang 他 · Journal of translational medicine · 2025

    BACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has garnered substantial scientific and clinical interest, due to its rising global prevalence and significant pathophysiological overlap with post-acute COVID-19 syndrome (PACS). This review systematically elucidates the prevailing diagnostic criteria, summarizes recent advances in understanding the potential pathophysiologic…

    📄 PubMed で読む (PMID: 41366804)
  • Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview.

    David Mantle, Iain Parry Hargreaves, Joan Carles Domingo 他 · International journal of molecular sciences · 2024

    Post-viral fatigue syndrome (PVFS) encompasses a wide range of complex neuroimmune disorders of unknown causes characterised by disabling post-exertional fatigue, myalgia and joint pain, cognitive impairments, unrefreshing sleep, autonomic dysfunction, and neuropsychiatric symptoms. It includes myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS); fibromyalgia (FM); and more …

    📄 PubMed で読む (PMID: 38203745)
  • Underuse of Pharmacologic Therapies for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Before Specialist Evaluation.

    Stephanie L Grach, Jaime Seltzer, Michael R Mueller 他 · Annals of family medicine · 2026

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multisystem neurologic disease characterized by profound fatigue and decreased functional capacity, postexertional malaise, and unrefreshing sleep, along with cognitive impairment and/or orthostatic intolerance. Its prevalence has risen exponentially with the COVID-19 pandemic. Pharmacologic therapies have been used successfully by M…

    📄 PubMed で読む (PMID: 42055743)
  • Low-dose Naltrexone Improves post-COVID-19 condition Symptoms.

    Leonardo Tamariz, Elizabeth Bast, Nancy Klimas 他 · Clinical therapeutics · 2024

    Treatments for myalgic encephalomyelitis and chronic fatigue syndrome can be adapted for post-COVID-19 condition. Our aim was to compare treatments in patients from our post-COVID-19 clinic. We conducted a retrospective cohort study and included consecutive patients enrolled in our post-COVID-19 clinic. We included patients who received low-dose naltrexone, amitriptyline, duloxetine, and physical …

    📄 PubMed で読む (PMID: 38267326)